Development and evaluation of nitrendipine nanoemulsion for intranasal delivery

Journal of Biomedical Nanotechnology

Volumn 5, Issue 1, 2009, Pages 62-68

  Jain, Ratnesh ^a   Patravale, Vandana B ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Histopathological studies; In vivo absorption; Intranasal drug delivery; Nanoemulsion; Nitrendipine

Indexed keywords

HISTOPATHOLOGICAL STUDIES; IN VIVO ABSORPTION; INTRANASAL DRUG DELIVERY; NANOEMULSION; NITRENDIPINE;

ABSORPTION; BIOCHEMISTRY; CARBOXYLIC ACIDS; DRUG DELIVERY; HYDRAULIC STRUCTURES; PHASE DIAGRAMS; PYRIDINE; SURFACE ACTIVE AGENTS;

PLASMAS;

CARDIF BETA; DIETHYLENE GLYCOL MONOETHYL ETHER; NITRENDIPINE; POLYSORBATE 80; PROPANEDIOL DERIVATIVE; SOLUTOL HS 15; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG SOLUBILITY; EVALUATION; HISTOPATHOLOGY; MAXIMUM PLASMA CONCENTRATION; NANOEMULSION; NONHUMAN; PARTICLE SIZE; RABBIT; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, INTRANASAL; ANIMALS; DRUG CARRIERS; DRUG COMPOUNDING; EMULSIONS; MATERIALS TESTING; NANOPARTICLES; NITRENDIPINE; PARTICLE SIZE; RABBITS;

EID: 67649764427     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2009.031     Document Type: Article

References (24)

1. K. L. Goa and E. M. Sorkin, Nitrendipine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs 33, 123 (1987).
2. C. R. Behl, H. K. Pimplaskar, A. P. Sileno, J. DeMeireles, and V. D. Romeo, Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv. Drug Deliv. Rev. 29, 89 (1998).
3. C. K. Kim, S. A. Ryuu, K. M. Park, S. L. Lim, and S. J. Hwang, Preparation and physiochemical characterization of phase inverted water/oil microemulsion containing cyclosporin A. Int. J. Pharm. 147, 131 (1996).
4. E. E. Linn, Microemulsion for intradermal delivery of cetyl alcohol and octyl dimethyl PABA. Drug Dev. Ind. Pharm. 16, 899 (1990).
5. M. A. Thevenin, J. L. Grossiord, and M. C. Poelman, Sucrose esters/cosurfactant microemulsion systems for transdermal delivery: Assessment of bicontinuous structures. Int. J. Pharm. 137, 177 (1996).
6. C. V. Corswant, P. Thoren, and S. Engstrom, Triglyceridebased microemulsion for intravenous administration of sparingly soluble substances. J. Pharm. Sci. 87, 200 (1998).
7. T. T. Kararli, T. E. Needham, G. Schoenhard, D. A. Baron, R. E. Schmidt, B. Katz, and B. Belonio, Enhancement of nasal delivery of a renin inhibitor in the rat using emulsion formulations. Pharm. Res. 9, 1024 (1992).
8. T. T. Kararli, T. E. Needham, M. Griffin, G. Schoenhard, L. J. Ferro, and L. Alcorn, Oral delivery of a renin inhibitor compound using emulsion formulations. Pharm. Res. 9, 888 (1992).
9. L. Li, I. Nandi, and K. H. Kim, Development of an ethyl laurate-based microemulsion for rapid-onset intranasal delivery of diazepam. Int. J. Pharm. 237, 77 (2002).
10. K. T. Ko, T. E. Needham, and H. Zia, Emulsion formulations of testosterone for nasal administration. J. Microencapsul. 15, 197 (1998).
11. N. Yamamoto, M. Sugimoto, H. Sakakibara, M. Saita, Y. Shimozono, and T. Manako, Calcitonin containing emulsion for nasal administration. Eur. Pat. Appl. EP 471618 (1992).
12. N. Yamamoto, M. Sugimoto, S. Morimoto, H. Sakakibara, M. Saita, Y. Shimozono, and T. Manako, Pharmaceutical emulsion containing parathyroid hormone for pernasal administration. PCT Int. Appl. WO 9305805 (1993).
13. O. Sonneville-Aubrun, J. T. Simonnet, and F. L'Alloret, Nanoemulsions: A new vehicle for skincare products. Adv. Col. Int. Sci. 108-109, 145 (2004).
14. J. Blanchard, Effect of polyols on interaction of paraben preservatives with polysorbate 80. J. Pharm. Sci. 69, 169 (1980).
15. M. M. Nerurkar, P. S. Burton, and R. T. Borchardt, The use of surfactants to enhance the permeability of peptides through caco-2 cells by inhibition of an apically polarized efflux system. Pharm. Res. 13, 528 (1996).
16. R. Strickley, Solubilizing excipients in oral and injectable formulations. Pharm. Res. 21, 201 (2004).
17. K. Buszello, S. Harnisch, R. H. Müller, and B. W. Müller, The influence of alkali fatty acids on the properties and the stability of parenteral OAV emulsions modified with Solutol HS 15. Eur. J. Pharm. Biopharm. 49, 143 (2000).
18. M. C. Lamas, L. Villaggi, I. Nocito, G. Bassani, D. Leonardi, F. Pascutti, E. Serra, and C. J. Salomón, Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole. Int. J. Pharm. 307, 239 (2006).
19. H. S. Gwak and I. K. Chun, Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int. J. Pharm. 236, 57 (2002).
20. C. V. Corswant and P. E. Thoren, Solubilization of sparingly soluble active compounds in lecithin-based microemulsions: Influence on phase behavior and microstructure. Langmuir 15, 3710 (1999).
21. Y. Zhang, X. G. Jie, and Y. Jiang, Lowering of sodium deoxycholate-induced nasal ciliotoxicity with cyclodextrins. Acta. Pharmacol. Sin. 22, 1045 (2001).
22. S. Gizurarson, P. Sigurdsson, T. Thorvaldsson, and E. Gunnarsson, Technique for administering drugs to the brain and bypassing the blood-brain-barrier. Scand. J. Lab. Animal Sci. 22, 273 (1995).
23. G. Antolic, F. Kozjek, and S. Primozic, The relevance of nitrendipine erythrocyte partitioning for the variability of its bioavailability parameters. Int. J. Pharm. 215, 147 (2001).
24. Y. Mingshi, C. Fude, Y. Bengang, Y. Jian, W. Liang, Z. Liqiang, and K. Yoshiaki, A novel pH-dependent gradient-release delivery system for nitrendipine I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs. J. Control. Release. 98, 219 (2004).